Patent
Anti-angiogenic compositions and methods of use
William L. Hunter,Lindsay S. Machan,A. Larry Arsenault +2 more
- 19 Jul 1994
1.2K
TL;DR: In this article, an anti-angiogenic factor and a polymeric carrier were used for embolization of blood vessels and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
read more
Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Patent
Implantable or insertable medical devices containing miscible polymer blends for controlled delivery of a therapeutic agent
Mariene C. Schwarz
- 06 Mar 2003
TL;DR: In this paper, the authors describe a release region for a therapeutic agent that regulates the rate of release of the therapeutic agent from the medical device upon implantation or insertion of the device into a patient.
40
Patent
Dry mouldable drug formulation
Thomas Buch-Rasmussen,James M. Flink,Jens Ulrich Poulsen,Soren Aasmul,Philip Edgar Hansen,Claus Juul-Mortensen +5 more
- 13 Apr 2000
TL;DR: Solid pharmaceutical compositions for parenteral injection comprising a binder and at least one therapeutic agent are described in this article, where the pharmaceutical composition has the strength to be injected directly with the need of using cannulas or the like.
40
Patent
Block copolymers of acrylates and methacrylates with fluoroalkenes
Charles D. Claude
- 10 Nov 2004
TL;DR: In this article, a block copolymer comprising a fluorinated block and a non-fluorinated block is described and a coating on an implantable device comprising the block and the method of using it is described.
40
Patent
Self-contained, self-piercing, side-expelling marking apparatus
Steven E. Field,Ryan L. Goosen,Brian R. Mulder,Richard M. Chesbrough +3 more
- 19 Jul 2005
TL;DR: A self-contained, self-piercing, and side-expelling marking apparatus for percutaneously placing a imaging marker in a tissue mass is described in this paper, where the marker is placed in the tissue mass.
39
Patent
Solvating system and sealant for medical use in the middle or inner ear
James B. Hissong,Dana A. Oliver,Cecil O. Lewis,Matthew F. Myntti +3 more
- 24 Apr 2007
TL;DR: In this article, a solvating system containing greater than 0.2 wt. % surfactant to a bacterial biofilm in the middle or inner ear, disrupting the biofilm, and applying a protective layer of a polymeric film-forming medical sealant.
39
References
The pathogenesis of atherosclerosis: a perspective for the 1990s
TL;DR: The ability to control the expression of genes encoding these molecules and to target specific cell types provides opportunities to develop new diagnostic and therapeutic agents to induce the regression of the lesions and, possibly, to prevent their formation.
11.4K
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.
TL;DR: It is shown that vascular endothelial growth factor (VEGF) probably functions as a hypoxia-inducible angiogenic factor and is specifically induced in a subset of glioblastoma cells distinguished by their immediate proximity to necrotic foci and the clustering of capillaries alongside VEGF-producing cells.
4.9K
A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease
Patrick W. Serruys,P. de Jaegere,Ferdinand Kiemeneij,Carlos Macaya,Wolfgang Rutsch,Gr. Heyndrickx,H. Emanuelsson,Jean Marco,Victor Legrand,P. Materne +9 more
TL;DR: The clinical and angiographic outcomes were better in patients who received a stent than in those who received standard coronary angioplasty, however, this benefit was achieved at the cost of a significantly higher risk of vascular complications at the access site and a longer hospital stay.
A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease
David L. Fischman,Martin B. Leon,Donald S. Baim,Richard A. Schatz,Michael P. Savage,Ian M. Penn,Katherine D. Detre,Lisa Veltri,Donald R. Ricci,Masakiyo Nobuyoshi,Michael W. Cleman,Richard R. Heuser,David Almond,Paul S. Teirstein,R. David Fish,Antonio Colombo,Jeffrey C. Brinker,Jeffrey Moses,Alex Shaknovich,John N. Hirshfeld,Stephen Bailey,Stephen E. Ellis,Randal Rake,Sheldon Goldberg +23 more
TL;DR: In selected patients, placement of an intracoronary stent, as compared with balloon angioplasty, results in an improved rate of procedural success, a lower rate of angiographically detected restenosis, a similar rate of clinical events after six months, and a less frequent need for revascularization of the original coronary lesion.
Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.
Donald R. Senger,Stephen J. Galli,Ann M. Dvorak,Carole A. Perruzzi,V. Susan Harvey,Harold F. Dvorak +5 more
TL;DR: Tumor ascites fluids from guinea pigs, hamsters, and mice contain activity that rapidly increases microvascular permeability, and this activity is secreted by these tumor cells and a variety of other tumor cell lines in vitro.
4.2K
Related Papers (5)
Ni Ding,Michael N. Helmus +1 more
- 19 Jun 1998
Eric P. Berg,Ronald J. Tuch,Michael Dror,Rodney G. Wolff +3 more
- 07 Jun 1995